Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03715465 · ClinicalTrials.gov registry record · Phase 3
The Clinical Utility of Measuring the Circadian Clock in Treatment of Delayed Sleep-Wake Phase Disorder
A Phase 3 study, sponsored by University of Michigan.
- Completed
- Registry status
- Phase 3
- Development phase
- 44
- Enrollment target
NCT03715465 is a Phase 3 study that has completed, run by University of Michigan. The registered enrollment target is 44 participants.
The verdict
NCT03715465, a Phase 3 study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 44 participants
- Enrollment target
Study Summary
This study will test whether measuring the circadian clock during treatment of delayed sleep-wake phase disorder results in greater improvements in sleep compared to estimating the circadian clock.
Interventions
- DRUG Melatonin 0.5 MG
- OTHER Dim Light Melatonin Onset (salivary)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2019-02-15 |
| Est. Completion | 2021-11-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03715465
The ClinicalTrials.gov registry entry for NCT03715465 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Melatonin 0.5 MG is the first listed.
NCT03715465 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03715465 about?
NCT03715465 is a clinical study titled "The Clinical Utility of Measuring the Circadian Clock in Treatment of Delayed Sleep-Wake Phase Disorder". This study will test whether measuring the circadian clock during treatment of delayed sleep-wake phase disorder results in greater improvements in sleep compared to estimating the circadian clock.
What is the current status of trial NCT03715465?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 44 participants. The study started on 2019-02-15. Estimated completion is 2021-11-05.
What interventions are being tested in trial NCT03715465?
The interventions under investigation include: Melatonin 0.5 MG (DRUG), Dim Light Melatonin Onset (salivary) (OTHER).
Who is sponsoring clinical trial NCT03715465?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.